Search results
Author(s):
Otto A Smiseth
,
Anders Opdahl
,
Espen Boe
,
et al
Added:
3 years ago
Abstract
Heart failure with preserved left ventricular ejection fraction (HF-PEF), sometimes named diastolic heart failure, is a common condition most frequently seen in the elderly and is associated with arterial hypertension and left ventricular (LV) hypertrophy. Symptoms are attributed to a stiff left ventricle with compensatory elevation of filling pressure and reduced ability to increase…
View more
Author(s):
Jindrich Spinar
,
Lenka Spinarová
Added:
3 years ago
Acute heart failure (AHF) is a major and growing cause of in-hospital mortality in developed countries. The prevalence of HF in an unselected population >45 years of age is estimated to be 2% and in a population >65 years of age is estimated to be 8.8%.1,2 The combination of aging of the population in many countries and improved survival after acute myocardial infarction has created rapid…
View more
Author(s):
Rani Upadhyay
,
Hussayn Alrayes
,
Scott Arno
,
et al
Added:
2 years ago
Author(s):
Mikhail Kosiborod
Added:
1 year ago
In this short interview, Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) summarises the main findings of the EMPULSE study, originally presented as a late-breaking trial at ACC.22(NCT04157751).
The study investigated the effects of empagliflozin on symptoms,physical limitations and quality of life inacute heart failure. The trial demonstrated that treatment with empagliflozin…
View more
Author(s):
Shanmugam Uthamalingam
,
James L Januzzi
Added:
3 years ago
Several cardiac biomarkers may aid in the diagnostic and prognostic evaluation of acute and chronic heart failure. In this article we discuss more novel and emerging applications of such established cardiac biomarkers in heart failure and review emerging data for several other promising markers.
Novel Applications of Established Cardiac Biomarkers—Natriuretic Peptides
B-type natriuretic peptide…
View more
Added:
1 year ago
HFSA 22 - In this interview, Dr Juuso Blomster (Precordior Ltd, Turku, FI) joins us to share the results of the REFLECS Trial (NCT04378179), originally presented at HFSA 2022.
This trial aimed to evaluate the Precordior CardioSignal app's efficacy in measuring patients cardiac motion and function in comparison to echocardiography. Over 200 patients were recruited to this observational study.
…
View more
Author(s):
William T Abraham
Added:
3 years ago
Hyponatremia is the most common electrolytic abnormality in clinical practice and has a reported incidence of 15–30% in adults.1,2 It is particularly common in heart failure: the Organized Program to Initiate Life Saving Treatment in Patients Hospitalized for Heart Failure (OPTIMIZE-HF) registry recorded that 25.3% of 47,647 heart failure patients had hyponatremia on admission.3 In this registry,…
View more
Author(s):
Hisham A Badreldin
,
Khalid bin Saleh
,
Majed Al-Yami
Added:
3 years ago
WRAP-IT
The Worldwide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT) was a prospective multicenter study to determine the safety and efficacy of an absorbable surgical mesh envelope containing two antibiotics (minocycline and rifampin) in reducing infection incidence in patients with cardiac implantable electronic devices compared to standard care.1 Approximately 7,000…
View more
Acute Heart Failure Syndromes
Author(s):
Mihai Gheorghiade
Added:
3 years ago
Article
Author(s):
Michael T Cain
,
Michael S Firstenberg
,
Joseph C Cleveland Jr
Added:
2 years ago